Cloranfenil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cloranfenil

What is Cloranfenil?

Cloranfenil is a pharmaceutical formulation containing chloramphenicol, a broad-spectrum antibiotic. It is primarily utilized for the treatment of various bacterial infections where other, less potent antibiotics may be ineffective or contraindicated.

Therapeutic Classification

Chloramphenicol belongs to the class of antibiotics known as amphenicols. It functions by inhibiting bacterial protein synthesis, effectively preventing the growth and replication of susceptible microorganisms. Because of its specific mechanism of action, it is often reserved for serious infections caused by organisms that are resistant to other antimicrobial agents.

Clinical Applications

Cloranfenil is typically indicated for the treatment of severe infections, including:

  • Ophthalmic Infections: It is commonly prepared as an ointment or solution for treating bacterial conjunctivitis and other superficial ocular infections.
  • Otitis Externa: It may be used in ear drop formulations to address bacterial infections of the external ear canal.
  • Systemic Infections: In specific clinical settings, chloramphenicol is used for life-threatening conditions such as typhoid fever, meningitis, and rickettsial infections, particularly when alternative treatments are not viable.

Mechanism of Action

The active ingredient works by binding to the 50S subunit of the bacterial ribosome. This action blocks the enzyme peptidyl transferase, which prevents the linkage of amino acids into peptide chains. By halting this essential biological process, the medication stops the bacteria from producing the proteins necessary for survival and multiplication.

Regulatory References

  1. World Health Organization (WHO)
  2. WHO Essential Medicines List

What side effects are possible with Cloranfenil?

Cloranfenil: Possible side effects and safety information

Cloranfenil (also known as Chloramphenicol) carries significant safety warnings and is typically reserved for serious infections when less toxic agents are ineffective or cannot be used. Its use is limited due to the potential for severe, life-threatening adverse reactions primarily affecting the blood and nervous systems.

Serious and Clinically Significant Adverse Reactions

The most serious risk is Fatal Aplastic Anemia, a rare, idiosyncratic, and irreversible blood disorder that can occur after both short-term and long-term use, and is not clearly dose-related. Systemic use also carries a risk of Bone Marrow Suppression, a dose-related and typically reversible condition resulting in low blood cell counts (e.g., anemia, neutropenia, thrombocytopenia).

A unique, life-threatening condition called Gray Syndrome (characterized by abdominal distension, progressive pallor, cyanosis, and cardiovascular collapse) can occur in premature and newborn infants due to their inability to effectively process the drug. Neurotoxicity, including Optic Neuritis and Peripheral Neuropathy, has been reported and may lead to vision loss if the drug is not immediately discontinued.

System-Organ Class Key Adverse Reactions (Systemic Use)
Blood & Lymphatic System Aplastic Anemia (fatal), Bone Marrow Suppression, Thrombocytopenia
Nervous System Optic Neuritis, Peripheral Neuropathy, Headaches
Gastrointestinal Nausea, Vomiting, Diarrhea, Clostridioides difficile-associated diarrhea (CDAD)
Hypersensitivity Anaphylaxis, Angioedema, Urticaria

Safety Considerations and Restrictions

Cloranfenil is contraindicated in individuals with a history of hypersensitivity to the drug, or those with acute porphyria or pre-existing bone marrow disease. Due to the risk of Gray Syndrome, it should be used with extreme caution and dosage adjustments in neonates, premature infants, and patients with impaired liver or kidney function. Therapeutic drug monitoring (TDM) of plasma concentrations and routine blood counts are often necessary during systemic treatment to manage the risk of bone marrow suppression.

Overdose and Emergency Response

In the event of an overdose or excessive exposure to Cloranfenil (Chloramphenicol), immediate medical attention is required. Overexposure to this medicine has been associated with significant, potentially delayed, toxic effects on various bodily systems, necessitating prompt emergency response.

Documented Overdose Manifestations

Symptoms following large exposures may appear later and often affect the blood, nervous system, and circulation. Documented presentations include:

  • Circulatory/Skin Changes: Shock, blue or gray discoloration of the skin (a feature of 'Gray Baby Syndrome' in infants), and low body temperature.
  • Hematologic Changes: Alterations in the blood count/composition, which may manifest as pale skin or unusual bruising.
  • Neurological/Visual Disturbances: Impairment of the nervous system, which can lead to confusion, drowsiness, sensory disturbances, and blurred or reduced vision.

When to Seek Immediate Medical Help

Always contact a Poison Control Center or emergency services immediately if overdose is suspected.

If a large quantity is ingested or if any of the above serious symptoms—such as a gray skin color, severe drowsiness, or signs of shock—become apparent, the patient should be taken to a hospital without delay. The management of Cloranfenil overexposure typically involves supportive care and may include specific interventions like the use of activated charcoal or, in severe cases, procedures to remove the drug from the body, particularly in high-risk populations like neonates.

Therapeutic Uses of Cloranfenil

What Cloranfenil Treats: Main Uses and Benefits

The primary role of Chloramphenicol (Cloranfenil) is to address bacterial infections, and it may be applied in contexts where additional symptomatic support is needed, focusing on symptom management and supporting patient stability. This broad-spectrum antibiotic is used for both superficial infections and as a reserve agent for severe systemic illnesses.


Therapeutic Contexts and Benefits

This antibiotic is generally reserved for managing conditions associated with severe systemic bacterial infection such as typhoid fever and bacterial meningitis. Its use supports the patient and plays a role in managing the infection, while contributing to easing severe symptoms related to systemic imbalance, including high fever, severe headache, and signs of severe systemic toxicity. This is relevant in clinical settings marked by temporary physiological imbalance.

For localized use, Chloramphenicol is commonly used in its topical forms to treat superficial bacterial infections of the eyes (like bacterial conjunctivitis) and the external ear canal (otitis externa). The treatment helps address symptom clusters of redness, irritation, localized pain, and purulent discharge that interfere with daily functioning. A key therapeutic benefit here is the support for the reduction of inflammatory states and localized discomfort.


Quick Fact: Relief for Inflammatory Symptoms

Chloramphenicol is considered relevant in conditions characterized by periods of heightened symptoms, specifically those involving inflammatory or irritative processes. The therapeutic support it provides may assist with maintaining functional stability by easing the overall symptom load.

Regulatory References

  1. NIH StatPearls overview

Eligibility and Restrictions for Use

Chloramphenicol (Cloranfenil) is typically reserved for serious infections where less potentially dangerous medicines are ineffective or contraindicated, due to the risk of severe, sometimes fatal, blood dyscrasias, such as aplastic anemia.

Populations for Whom Use is Prohibited or Restricted

Classification Eligibility Status Specific Group/Condition
Contraindicated Prohibited Known hypersensitivity to chloramphenicol
Contraindicated Prohibited History of myelosuppression from previous exposure
Contraindicated Prohibited Personal or family history of blood dyscrasias (e.g., aplastic anemia)
Not Recommended Restricted/Avoided Newborn/Premature infants (risk of 'Gray Syndrome')
Not Recommended Restricted/Avoided During pregnancy and lactation
Caution/Monitoring Special Consideration Individuals with hepatic or renal impairment
Caution/Avoid Special Consideration Patients receiving other drugs known to suppress bone marrow function

Regulatory authorities explicitly state that use must be avoided in trivial infections or for prophylaxis. In cases of restricted use, such as in neonates or patients with liver issues, careful dosing adjustments and serum concentration monitoring are essential to minimize the risk of serious adverse effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify the interactions of Cloranfenil (Chloramphenicol) based on its ability to interfere with drug metabolism and function. The product is documented as an inhibitor of key cytochrome P450 (CYP) enzymes, specifically mathrmCYP2mathrmC9, mathrmCYP2mathrmC19, and mathrmCYP3mathrmA4. This mechanism is the primary basis for its drug-drug interactions.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Mechanism/Effect Interacting Product Category Example Medicines Listed in Regulatory Documents
Increased Plasma Levels CYP Substrates (mathrmCYP2mathrmC9, mathrmCYP2mathrmC19, mathrmCYP3mathrmA4) Warfarin, Phenytoin, Tacrolimus, Cyclosporine, Sulphonylureas
Additive/Synergistic Risk Bone Marrow Depressants Azathioprine, Methotrexate
Antagonistic Effect Live Bacterial Vaccines BCG Vaccine, Cholera Vaccine Live

Official Constraints and Restrictions

Co-administration with medicines known to depress bone marrow function is a primary constraint and is officially stated to be avoided. For products metabolized by the affected CYP enzymes (e.g., Warfarin, Phenytoin), the interaction results in increased exposure to the co-administered medicine, a factor that requires careful consideration. Additionally, co-administration with Iron or Vitamin mathrmB12 supplements may decrease the therapeutic response to these supplements. Administration requirements advise that live bacterial vaccines should be given only after the course of treatment with Cloranfenil is completed.

Mechanism of Action

Chloramphenicol, the active component, operates by disrupting the fundamental process of protein synthesis in susceptible bacteria. The drug acts as a specific, reversible inhibitor by targeting the bacterial 50S ribosomal subunit.

Targeting the Bacterial Protein Synthesis Machinery

The molecule binds within the peptidyl transferase (PTase) center, physically blocking the A (acceptor) site of the ribosome. This molecular obstruction prevents the formation of peptide bonds and arrests the elongation of all protein chains. This direct, targeted inhibition results in the primary physiological effect of arresting bacterial growth, known as bacteriostatic action.

Mechanism Limitations and Defense Pathways

The efficacy of this mechanism is biologically constrained by bacterial defense pathways. The mechanism is specifically limited when bacteria produce the enzyme Chloramphenicol acetyltransferase (CAT), which chemically inactivates the drug before it can bind to the 50S target. These limitations define the scope of the drug’s physiological action profile by constraining the effective mechanism.

Dosage and Administration Information

How to Use Chloramphenicol

Chloramphenicol administration is differentiated by form, targeting either systemic or localized infection sites, following established clinical standards for treatment.

Administration Routes and Dosing

The medicine is indicated for several distinct routes. For systemic treatment, it is administered either intravenously (IV) or orally. The Intramuscular (IM) route is discouraged due to evidence of slow and inconsistent absorption. Topical forms include ophthalmic drops and ointment for the eye, and otic drops for the ear.

For systemic use, the standard adult regimen is 50 mg/kg/day of the Chloramphenicol base, divided into four equal doses taken at 6-hour intervals to maintain consistent levels. In severe cases like meningitis, the initial dose may temporarily be increased to 100 mg/kg/day, but is reduced to the standard dose as soon as clinically appropriate. Oral forms are generally taken on an empty stomach (e.g., 1 hour before or 2 hours after a meal) with water.

Specific Usage Protocols

Usage Constraint Clinical Instruction
Pediatric Dosing Neonates under 2 weeks require a total daily dose of 25 mg/kg in divided doses.
Duration of Course Treatment for typhoid fever is continued for 8 to 10 days after the fever subsides. Topical courses are limited to a maximum of 7 days.
Injection Preparation The 1 g injectable powder is reconstituted with 10 mL of an aqueous diluent to a 100 mg/mL solution and is injected over at least a one-minute interval.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Initial Findings

Research has explored the compound's characteristics. Studies have examined whether the compound's properties relate to a reduction in symptoms for individuals. This approach has been the subject of recent clinical investigation.

Research has explored the onset and duration of symptom changes in individuals experiencing chronic pain. Data was collected across different dose levels to evaluate the frequency and intensity of reported changes. Research findings related to long-term symptom management remain under evaluation.

Combination Therapy Review

Studies evaluated whether the combination treatment was associated with improved outcomes when compared to the single compound alone. Researchers investigated whether adding a secondary agent influenced the rate of reported symptom changes or the overall individual response. Results from the phase II trials indicated varied individual responses to the combination approach.

Research Scope and Administration

Research investigated the compound in several key patient populations. Studies explored potential risks associated with the compound in individuals with pre-existing heart conditions. Trial monitoring focused on cardiovascular markers to assess any potential associations.

The duration of administration has been limited to 4 weeks in the clinical trials reviewed. Investigators monitored participants for potential adverse effects related to prolonged use. Data reviewed pertains to the short-term use evaluated in the conducted trials.


Important Note on Clinical Suitability:

Consultation with a healthcare professional is necessary before considering any treatment. This information is a summary of research findings and does not constitute medical advice, diagnosis, or recommendations for treatment suitability.

Frequently Asked Questions (FAQ)

Common questions about Cloranfenil (FAQ)

Q: Why is Cloranfenil not used as often as other antibiotics?

A: Cloranfenil is typically reserved for serious infections when other, less potentially hazardous therapeutic agents are not effective or cannot be used. This cautious approach is due to the potential for serious side effects, including rare but fatal blood disorders such as aplastic anemia, which is highlighted in official warnings.

Q: Can children safely take Cloranfenil, and is it a different dose?

A: Regulatory information indicates that Cloranfenil is reserved for use in children under highly restricted conditions and requires close medical monitoring. Official guidance specifies that careful dosage adjustments are essential for all children, particularly premature infants and newborns, to minimize the risk of drug accumulation and potential harm.

Q: What should I do if I miss a dose of Cloranfenil?

A: General patient information for antibiotic use often suggests that if a dose is missed, it should be taken as soon as it is remembered. If it is close to the time for the next scheduled dose, general guidance suggests skipping the missed dose entirely and continuing the regular schedule to avoid taking too much medication at once.

Q: Are there any foods or drinks I need to avoid while on Cloranfenil?

A: Official administration instructions for the oral form of Cloranfenil often advise taking it on an empty stomach to facilitate proper absorption. Furthermore, official patient information often suggests avoiding or limiting alcohol consumption while taking antibiotics, as it may increase the risk of side effects.

Q: Is it normal to feel a bit nauseous after starting Cloranfenil?

A: Yes, regulatory documents list nausea, vomiting, and diarrhea as common side effects associated with this medication. If these effects are severe or concerning, seeking guidance from a healthcare professional is important.

Q: Can Cloranfenil affect my ability to drive or operate machinery?

A: Official information for the ophthalmic (eye) forms of Cloranfenil warns that they may cause temporary blurring of vision after administration. If blurred vision occurs, it is advised to wait until vision is clear before performing activities like driving or operating machinery.

Q: Does Cloranfenil interact with supplements like vitamins or herbal remedies?

A: Yes, Cloranfenil may interfere with the effects of certain supplements, such as Vitamin B12 and Iron. Official guidance emphasizes the importance of informing a healthcare provider about all supplements, including vitamins and herbal remedies, that are being used.

Q: Can Cloranfenil treat meningitis?

A: Official indications confirm that Cloranfenil is used for the treatment of certain types of bacterial meningitis. Its use for this serious infection is reserved for situations where less hazardous alternative medicines are not effective or are contraindicated.

Q: What happens if you stop taking Cloranfenil before the prescription is finished?

A: General patient information indicates that stopping an antibiotic course prematurely may not completely eliminate the bacteria causing the infection. This can lead to a return of the infection and potentially contribute to the development of antibiotic-resistant bacteria.

Q: Is Cloranfenil available over the counter anywhere?

A: The systemic forms (capsules or injections) are strictly available only by prescription. In some jurisdictions, however, certain low-strength topical forms, such as eye drops or ointment, may be available without a prescription for localized use in specific patient groups.

Q: Can Cloranfenil be used in pets like dogs or cats?

A: Yes, Chloramphenicol is officially approved for veterinary use by prescription to treat specific bacterial infections in animals such as dogs. However, its use is strictly prohibited in animals intended for human food production.

Q: Are there any long-term side effects associated with Cloranfenil use?

A: Official safety information documents that irreversible aplastic anemia, a potentially fatal blood disorder, can occur after both short and prolonged use. Additionally, neurotoxicity, such as damage to the optic nerve or peripheral nerves, has been reported with prolonged therapy.

Q: Is it safe to drink alcohol while taking Cloranfenil?

A: Official patient information often suggests avoiding or limiting the consumption of alcohol while taking antibiotics, including Cloranfenil. This is because alcohol can potentially increase the risk of side effects like nausea and vomiting, and may interact with the medication.

Q: Does Cloranfenil require a special kind of prescription?

A: Cloranfenil carries a Boxed Warning due to the risk of fatal blood dyscrasias. Its use is restricted to situations where less toxic drugs are ineffective or contraindicated, which may lead to stricter institutional prescribing guidelines and heightened medical oversight.

Q: What is the shelf life of Cloranfenil medication?

A: The official shelf life of the unopened product varies by the formulation (capsule, ointment, or injectable). Opened ophthalmic solutions (eye drops) typically have a limited in-use shelf life, often requiring them to be discarded after 21 to 28 days.

Q: Is Cloranfenil effective against all types of bacteria?

A: No. While Cloranfenil is classified as a broad-spectrum antibiotic, its effectiveness is limited to bacteria that are susceptible to its specific mechanism of action. Official documents note that bacterial resistance can occur when organisms produce an enzyme that inactivates the drug.

Q: Does Cloranfenil affect the kidneys?

A: While the drug is primarily processed by the liver, a portion of the drug is excreted by the kidneys. Official safety information advises that caution and dose adjustment are necessary for patients with pre-existing impaired renal (kidney) function, as the drug may accumulate in their system.

Q: What precautions should be taken when giving Cloranfenil to newborns?

A: Official guidance indicates that special precautions are necessary when Cloranfenil is administered to newborns. This includes using a low starting dosage and carefully monitoring the drug's concentration in the blood to prevent accumulation, which is required to mitigate the risk of Gray Syndrome.

Q: Why would a doctor prescribe Cloranfenil instead of a penicillin-based drug?

A: A doctor would typically prescribe Cloranfenil when other standard, less toxic agents, such as penicillin-based drugs, are ineffective. This decision is often based on factors like bacterial resistance or if the patient has a known contraindication, such as a severe allergy to penicillin.

Q: Does Cloranfenil come in an injectable form?

A: Yes, Cloranfenil is available in an injectable powder form (Chloramphenicol Sodium Succinate). This form is prepared for intravenous (IV) administration when systemic treatment is required for a serious infection.

Q: Is Cloranfenil used for typhoid fever?

A: Yes, official indications confirm that Cloranfenil is used for the treatment of acute infections of typhoid fever (caused by Salmonella typhi). Its use in this case is typically reserved for situations where less toxic alternatives have failed or cannot be used.

Q: How does Cloranfenil affect the natural balance of gut bacteria?

A: Like other broad-spectrum antibiotics, Cloranfenil can disrupt the natural, healthy balance of microorganisms in the digestive tract. This common effect can sometimes lead to gastrointestinal side effects, including diarrhea.

Q: Is it normal to have a metallic taste while on Cloranfenil?

A: Official side effect reports and drug compendiums indicate that alterations in taste, including an unusual or metallic taste (known as dysgeusia), have been reported as a side effect of this medication.

Q: What is the maximum duration of treatment for Cloranfenil?

A: The maximum duration of treatment is highly specific to the type of infection and the formulation. For example, official guidelines specify that topical eye drops are typically limited to a maximum of 7 days, while systemic treatment for serious infections like typhoid fever may last 8 to 10 days after the fever has subsided.

Q: Does Cloranfenil work well for ear infections?

A: Cloranfenil is officially manufactured as otic (ear) drops, which are indicated for the local treatment of certain susceptible bacterial ear infections. The selection of this drug for an ear infection depends on the specific bacteria identified.

Q: Does Cloranfenil interact with birth control pills?

A: Cloranfenil is a known inhibitor of liver enzymes (CYP enzymes) that metabolize hormonal medications, which can potentially affect the levels of oral contraceptives. Official guidance advises that additional or alternative methods of contraception may be necessary during the course of treatment.

Q: What makes Cloranfenil different from tetracycline antibiotics?

A: Cloranfenil is classified as a phenicol-class antibiotic, while tetracyclines are in the tetracycline class. They differ in their mechanism of action: Cloranfenil inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, whereas tetracyclines target the 30S ribosomal subunit.

Q: How do I know if the bacteria I have is resistant to Cloranfenil?

A: Determining bacterial resistance requires laboratory susceptibility testing of the organism causing the infection, as outlined in official guidelines. If no clinical improvement is observed within three to five days of starting treatment, the diagnosis and choice of antibiotic therapy should be reviewed by a healthcare provider.

How should Cloranfenil be stored and disposed of?

How to Store and Dispose of Cloranfenil

Official storage conditions for Chloramphenicol (Cloranfenil) vary by preparation and are mandated by regulatory labeling. The product must be stored out of the reach and sight of children.

Chloramphenicol capsules must be stored below 30°C and protected from light. Unopened ophthalmic solutions require refrigeration (2°C to 8°C), but must not be frozen. Once dispensed, the ophthalmic solution or ointment is typically stored at room temperature (15°C to 30°C), and the container must be kept tightly closed.

The in-use stability is limited for sterile forms; opened eye drops must be discarded after 21 to 28 days. Any unused or expired medicine must be disposed of in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cloranfenil found in:

A-Z Index: